Bottom line
HCPIX vs JEHSX: the short answer
HCPIX (Health Care Ultrasector Profund) and JEHSX (Health Sciences Trust) are both mutual funds.
But JEHSX is far broader, holding 173 positions to 69 for HCPIX, so beyond the top names it adds exposure HCPIX doesn't have.
JEHSX is cheaper at 1.04% vs 1.76% — a difference of $72 a year per $10,000 invested.
Over five years, HCPIX returned +6.4% a year vs +4.2% for JEHSX (reporting dates differ).
Updated Nov 19, 2026
HCPIX vs JEHSX side by side
| HCPIX | JEHSX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | ProShares | John Hancock |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.76% | 1.04% |
| Annual cost per $10k | $176 | $104 |
| 10-yr cost on $10k (prospectus) | $2,073 | $1,282 |
| Max front load | — | — |
| 12b-1 fee | 0% | 0.05% |
| 1-yr return | −1.4% | +19.5% |
| 5-yr return (annualized) | +6.4% | +4.2% |
| 10-yr return (annualized) | +9.2% | +8.7% |
| Best quarter | +22.0% | +23.6% |
| Worst quarter | −21.0% | −16.1% |
| Net assets (fund) | $12.1M | $251.3M |
| Number of holdings | 69 | 173 |
| Portfolio turnover | 99% | 68% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | HCPIX | JEHSX | Difference |
|---|---|---|---|
| 2024 | −1.4% | +1.8% | −3.1% |
| 2023 | −1.3% | +4.3% | −5.6% |
| 2022 | −10.6% | −13.1% | +2.5% |
| 2021 | +33.9% | +11.2% | +22.7% |
| 2020 | +16.9% | +27.2% | −10.3% |
| 2019 | +28.4% | +28.7% | −0.3% |
| 2018 | +5.0% | +0.7% | +4.3% |
| 2017 | +32.2% | +27.5% | +4.7% |
| 2016 | −6.5% | −10.6% | +4.1% |
Source: Fund prospectus bar charts
Holdings overlap
16 of HCPIX's top 25 holdings also appear in JEHSX's top 25.
| Holding | HCPIX | JEHSX |
|---|---|---|
| Eli Lilly & Company | 11.83% | 14.30% |
| Johnson & Johnson | 8.03% | 6.33% |
| Abbvie Inc | 5.77% | 5.28% |
| Unitedhealth Group Inc | 4.90% | 5.95% |
| Merck & Company Inc | 4.19% | 4.21% |
| Thermo Fisher Scientific Inc | 2.78% | 2.67% |
| Amgen Inc | 2.71% | 1.90% |
| Abbott Laboratories | 2.40% | 2.00% |
| Gilead Sciences Inc | 2.10% | 2.95% |
| Bristol-myers Squibb Company | 1.74% | 2.22% |
| Cvs Health Corp | 1.73% | 0.98% |
| Intuitive Surgical Inc | 1.63% | 1.98% |
| Danaher Corp | 1.60% | 1.51% |
| Vertex Pharmaceuticals Inc | 1.57% | 2.38% |
| Stryker Corp | 1.46% | 1.87% |
Source: SEC Form N-PORT
HCPIX top 10
- Eli Lilly & Company — 11.83%
- Johnson & Johnson — 8.03%
- N/a — 6.45%
- Abbvie Inc — 5.77%
- N/a — 4.97%
- Unitedhealth Group Inc — 4.90%
- Merck & Company Inc — 4.19%
- N/a — 3.96%
- N/a — 3.96%
- N/a — 3.11%
JEHSX top 10
- Eli Lilly and Company — 14.30%
- Johnson and Johnson — 6.33%
- UnitedHealth Group Incorporated — 5.95%
- AbbVie Inc. — 5.28%
- Merck and Co. Inc. — 4.21%
- Gilead Sciences Inc. — 2.95%
- Thermo Fisher Scientific Inc. — 2.67%
- Vertex Pharmaceuticals Incorporated — 2.38%
- Bristol-Myers Squibb Company — 2.22%
- Abbott Laboratories — 2.00%
FAQ
What is the difference between HCPIX and JEHSX?
Which is cheaper, HCPIX or JEHSX?
Should I own both HCPIX and JEHSX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.